Similar articles

• A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

  Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A. Schömig A, et al. J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80. doi: 10.1016/j.jacc.2007.06.047. Epub 2007 Aug 21. J Am Coll Cardiol. 2007. PMID: 17903638 Review.
• Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.

  Iijima R, Mehilli J, Schömig A, Kastrati A. Iijima R, et al. Minerva Cardioangiol. 2006 Oct;54(5):539-55. Minerva Cardioangiol. 2006. PMID: 17019392 Review.
• Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.

  Nordmann AJ, Briel M, Bucher HC. Nordmann AJ, et al. Eur Heart J. 2006 Dec;27(23):2784-814. doi: 10.1093/eurheartj/ehl282. Epub 2006 Oct 4. Eur Heart J. 2006. PMID: 17020889 Review.
• Cypher versus taxus: are there differences?

  Silber S. Silber S. J Interv Cardiol. 2005 Dec;18(6):441-6. doi: 10.1111/j.1540-8183.2005.00084.x. J Interv Cardiol. 2005. PMID: 16336424 Review.
• Taxus vs. Cypher: making sense of the 'evidence-based' data.

  Bhandari S, Dhall A, Tandon V, K S. Bhandari S, et al. Indian Heart J. 2007 Mar-Apr;59(2 Suppl B):B50-8. Indian Heart J. 2007. PMID: 19153437 Review. No abstract available.